These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10741902)

  • 21. Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") but not by fenfluramine.
    Dafters RI; Lynch E
    Psychopharmacology (Berl); 1998 Jul; 138(2):207-12. PubMed ID: 9718291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination.
    Baker LE; Taylor MM
    Pharmacol Biochem Behav; 1997 Aug; 57(4):737-48. PubMed ID: 9259001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro release of [3H]5-hydroxytryptamine from fetal and maternal brain by drugs of abuse.
    Kramer K; Azmitia EC; Whitaker-Azmitia PM
    Brain Res Dev Brain Res; 1994 Mar; 78(1):142-6. PubMed ID: 7911745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fenfluramine-induced immunosuppression: an in vivo analysis.
    Connor TJ; Kelly JP
    Eur J Pharmacol; 2002 Nov; 455(2-3):175-85. PubMed ID: 12445584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor activity and body temperature in the rat involve alpha-adrenoceptors.
    Bexis S; Docherty JR
    Br J Pharmacol; 2006 Apr; 147(8):926-34. PubMed ID: 16491100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute effects of dexfenfluramine (d-FEN) and methylenedioxymethamphetamine (MDMA) before and after short-course, high-dose treatment.
    Frederick DL; Ali SF; Gillam MP; Gossett J; Slikker W; Paule MG
    Ann N Y Acad Sci; 1998 May; 844():183-90. PubMed ID: 9668676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylenedioxymethamphetamine (MDMA; 'Ecstasy') suppresses antigen specific IgG2a and IFN-gamma production.
    Connor TJ; Connelly DB; Kelly JP
    Immunol Lett; 2001 Sep; 78(2):67-73. PubMed ID: 11672589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-choice discrimination among (+)-amphetamine, fenfluramine and saline in pigeons.
    Evans SM; Zacny JP; Johanson CE
    Pharmacol Biochem Behav; 1990 Apr; 35(4):971-80. PubMed ID: 1971722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MDMA and fenfluramine reduce L-DOPA-induced dyskinesia via indirect 5-HT1A receptor stimulation.
    Bishop C; Taylor JL; Kuhn DM; Eskow KL; Park JY; Walker PD
    Eur J Neurosci; 2006 May; 23(10):2669-76. PubMed ID: 16817869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
    Callaway CW; Wing LL; Geyer MA
    J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of d-fenfluramine on the lymphocyte response of HIV+ humans.
    Mathews HL; Goral J; Yamamura Y; Clancy J; Lorens SA
    Int J Immunopharmacol; 1998 Dec; 20(12):751-63. PubMed ID: 9877285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity.
    Paulus MP; Geyer MA
    Neuropsychopharmacology; 1992 Aug; 7(1):15-31. PubMed ID: 1355968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques.
    Crean RD; Davis SA; Von Huben SN; Lay CC; Katner SN; Taffe MA
    Neuroscience; 2006 Oct; 142(2):515-25. PubMed ID: 16876329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement.
    Fletcher PJ; Korth KM; Robinson SR; Baker GB
    Psychopharmacology (Berl); 2002 Jul; 162(3):282-91. PubMed ID: 12122486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters.
    Schuldiner S; Steiner-Mordoch S; Yelin R; Wall SC; Rudnick G
    Mol Pharmacol; 1993 Dec; 44(6):1227-31. PubMed ID: 7903417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discriminative profile of MDMA.
    Schechter MD
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1533-7. PubMed ID: 2874566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
    Lorens SA; Hata N; Cabrera T; Hamilton ME
    NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
    [No Abstract]   [Full Text] [Related]  

  • 39. Methylenedioxymethamphetamine suppresses production of the proinflammatory cytokine tumor necrosis factor-alpha independent of a beta-adrenoceptor-mediated increase in interleukin-10.
    Connor TJ; Harkin A; Kelly JP
    J Pharmacol Exp Ther; 2005 Jan; 312(1):134-43. PubMed ID: 15331655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats.
    Kehne JH; Padich RA; McCloskey TC; Taylor VL; Schmidt CJ
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):95-106. PubMed ID: 8935804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.